Attomarker constantly innovates and delivers

Gold Standard
Rapid Diagnostics

at the point-of-care

Advancing Long COVID Research: From Diagnostics to Therapies

Wednesday 14th August, 6-7pm GMT+1

Join Professor Andrew Shaw and Dr Ben Sinclair for a webinar on the latest breakthroughs in Long COVID research and therapy.

Suffering from Long Covid?

You can book an Attomarker Multi-Variant Antibody Immunity Spectrum to explore treatment options with partner clinics worldwide.*

Attomarker believes that new challenges to our health require innovative answers inspired by rigorous science.

For thousands of years clinicians have had to make diagnoses based on symptoms alone.  More recently we have had blood tests, but the results often arrive too late or are too uni-dimensional.

Attomarker offers rapid personalised multi-dimensional diagnosis that enables earlier treatment designed to meet your unique, individual healthcare needs.

High quality diagnosis, which can be mapped against symptoms using AI, will reach beyond the laboratory and be accessible to everyone, in clinics, pharmacies and at home.

 

 

*Clinican-led named-patient research test

 

7 reasons